Adams Wealth Management Abb Vie Inc. Transaction History

Adams Wealth Management

$433 Million
Q3 2024

A detailed history of Adams Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Adams Wealth Management holds 4,713 shares of ABBV stock, worth $848,340. This represents 0.21% of its overall portfolio holdings.

Number of Shares

4,713

Previous 5,014 6.0%

Holding current value

$848,340

Previous $860,000 8.14%

% of portfolio

0.21%

Previous 0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$163.84 - $199.33 $49,315 - $59,998	-301 Reduced 6.0%	4,713 $930,000
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $153,861 - $179,675	-994 Reduced 16.54%	5,014 $860,000
Q1 2024 May 20, 2024	SELL	$159.82 - $182.1 $88,540 - $100,883	-554 Reduced 8.44%	6,008 $1.09 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $15,273 - $17,201	-111 Reduced 1.66%	6,562 $1.02 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $97,253 - $112,585	-728 Reduced 9.84%	6,673 $994,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $41,873 - $52,108	316 Added 4.46%	7,401 $997,000
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $97,177 - $111,914	672 Added 10.48%	7,085 $1.13 Million
Q4 2022 Feb 17, 2023	BUY	$138.31 - $165.87 $45,642 - $54,737	330 Added 5.42%	6,413 $1.04 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $57,978 - $66,497	-432 Reduced 6.63%	6,083 $816,000
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $35,918 - $45,664	-261 Reduced 3.85%	6,515 $998,000
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $63,878 - $79,255	-484 Reduced 6.67%	6,776 $1.1 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $79,283 - $100,316	-738 Reduced 9.23%	7,260 $983,000
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $128,531 - $145,902	-1,208 Reduced 13.12%	7,998 $863,000
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $20,305 - $22,621	-193 Reduced 2.05%	9,206 $1.04 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $11,662 - $12,838	114 Added 1.23%	9,399 $1.02 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $39,923 - $53,900	-496 Reduced 5.07%	9,285 $995,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $8,848 - $10,385	-103 Reduced 1.04%	9,781 $857,000
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $18,856 - $25,232	-257 Reduced 2.53%	9,884 $970,000
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $36,700 - $55,642	-569 Reduced 5.31%	10,141 $773,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $772,512 - $966,577	10,710 New	10,710 $948,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Adams Wealth Management with notifications on news.

Account

Adams Wealth Management Abb Vie Inc. Transaction History